Research Article
Do Symptoms and Serum Calcium Levels Affect the Results of Surgical Treatment of Primary Hyperparathyroidism?
Table 1
Clinicopathological data of all patients.
| | Index | Patients (n=197) |
| | Age, y (IQR) | 49 (43-57) | | Female | 147 (74.62%) | | Male | 50 (25.38%) | | HCPHPT | 82.23% (162/197) | | NCPHPT | 17.77% (35/197) | | SPHPT | 45.18% (89/197) | | ASPHPT | 54.82% (108/197) | | Parathyroid adenoma | 81.73% (161/197) | | Parathyroid hyperplasia | 15.23% (30/197) | | Parathyroid carcinoma | 1.02% (2/197) | | Parathyroid adenoma with hyperplasia | 2.03% (4/197) | | PHPT with thyroid nodules | 39.09% (77/197) | | Papillary thyroid carcinoma | 43.14% (22/51) | | Nodular goiter | 56.86% (29/51) | | Cure rate of PHPT | 96.45% (190/197) | | Recurrence rate of PHPT | 1.52% (3/197) |
|
|
Abbreviations: IQR, interquartile range; HCPHPT, hypercalcemic primary hyperparathyroidism; NCPHPT, normocalcemic primary hyperparathyroidism; SPHPT, symptomatic primary hyperparathyroidism; ASPHPT, asymptomatic primary hyperparathyroidism; PHPT, primary hyperparathyroidism.
|
